Skip to content

13F-HR filed by Deep Track Capital, LP

Deep Track Capital, LP filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-12, with 51 holding rows worth $1,521,242,000.

Accession
0001856083-22-000011
Filed
2022-08-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2022

A holdings report, 51 entries on the cover page, a total value of $1,521,242,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,521,242,000 with VALUE read as thousands by filing date, 13F file number 028-21949. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GLOBAL BLOOD THERAPEUTICS USD37890U108COM3,646,690$116,512,000thousands by filing date
NOVOCURE LTDG6674U108ORD SHS1,341,300$93,220,000thousands by filing date
TRAVERE THERAPEUTICS INC89422G107COM3,580,700$86,760,000thousands by filing date
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock500,000$78,005,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock499,900$72,910,000thousands by filing datecall
KURA ONCOLOGY INC COM50127T109Stock3,697,969$67,784,000thousands by filing date
MADRIGAL PHARMACEUTICALS INC COM558868105Stock905,000$64,780,000thousands by filing date
CHINOOK THERAPEUTICS INC16961L106COM3,430,110$59,993,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM654,365$54,227,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM2,018,005$50,006,000thousands by filing date
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS2,900,000$48,662,000thousands by filing date
BEAM THERAPEUTICS INC07373V105COM1,250,000$48,388,000thousands by filing date
IVERIC BIO INC46583P102COM4,500,000$43,290,000thousands by filing date
AGENUS INC00847G705COM NEW22,241,417$43,148,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock6,000,000$38,160,000thousands by filing date
REPARE THERAPEUTICS INC760273102COM2,707,662$37,880,000thousands by filing date
NUVATION BIO INC COM CL A67080N101Stock11,471,281$37,167,000thousands by filing date
IMMUNOVANT INC45258J102COM9,455,000$36,875,000thousands by filing date
NKARTA INC65487U108COMMON STOCK2,814,844$34,679,000thousands by filing date
NURIX THERAPEUTICS INC67080M103COMMON STOCK2,436,164$30,866,000thousands by filing date
FORMA THERAPEUTICS HLDGS INC34633R104SHS4,050,000$27,905,000thousands by filing date
TRICIDA INC89610F101COM2,732,117$26,447,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM1,733,130$24,420,000thousands by filing date
DYNE THERAPEUTICS INC COM26818M108Stock3,500,000$24,045,000thousands by filing date
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock3,140,000$21,917,000thousands by filing date
KEROS THERAPEUTICS INC COM492327101Stock739,528$20,433,000thousands by filing date
CRINETICS PHARMACEUTICALS INC COM22663K107Stock1,053,000$19,638,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM1,824,000$17,948,000thousands by filing date
DICE THERAPEUTICS INC23345J104COM1,042,900$16,186,000thousands by filing date
INOZYME PHARMA INC45790W108COM3,250,000$15,503,000thousands by filing date
SCHRODINGER INC COM80810D103Stock562,000$14,842,000thousands by filing date
ACUMEN PHARMACEUTICALS INC00509G209CMN3,100,000$14,570,000thousands by filing date
ANAPTYSBIO INC032724106COM672,569$13,653,000thousands by filing date
VIRIDIAN THERAPEUTICS INC92790C104COM1,170,290$13,540,000thousands by filing date
ADICET BIO INC007002108COM892,028$13,024,000thousands by filing date
JOUNCE THERAPEUTICS INC481116101COM4,259,653$12,907,000thousands by filing date
SILENCE THERAPEUTICS PLC82686Q101ADS951,580$11,276,000thousands by filing date
RELMADA THERAPEUTICS INC75955J402COMMON STOCK500,000$9,495,000thousands by filing date
HOOKIPA PHARMA INC43906K100COM5,035,998$8,209,000thousands by filing date
CENTURY THERAPEUTICS INC15673T100COM924,641$7,767,000thousands by filing date
DIANTHUS THERAPEUTICS INC COM55910K108Stock5,359,000$6,431,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM3,000,000$6,300,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM171,800$5,549,000thousands by filing date
PASSAGE BIO INC702712100COM2,320,000$5,475,000thousands by filing date
GH RESEARCH PLC ORDINARY SHARESG3855L106Stock499,400$4,984,000thousands by filing date
FULCRUM THERAPEUTICS INC359616109COMMON STOCK1,000,000$4,900,000thousands by filing date
GRITSTONE BIO INC39868T105COM1,720,000$4,162,000thousands by filing date
TENAYA THERAPEUTICS INC87990A106COM483,836$2,724,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM260,500$2,061,000thousands by filing dateput
ATYR PHARMA INC002120202COM NEW290,844$823,000thousands by filing date
VIGIL NEUROSCIENCE INC92673K108COM308,393$796,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001856083-22-000011this filing2022-08-12acceptance time not in the bulk data set